Skip to content

Clinical trials

Phase 3 Dermatitis, Atopic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 3 Country / region: United States Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20082
20131
20147
20154
20162
20175
201818
20199
20206
20214
202210
202310
20249
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Active, not recruiting8
Terminated5
Recruiting4
Suspended1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company13
Pfizer13
AbbVie8
Amgen8
LEO Pharma8
Regeneron Pharmaceuticals7
Incyte Corporation6
Sanofi5
Organon and Co4
Acrotech Biopharma Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic93
Eczema42
Skin Diseases11
Dermatitis10
Pruritus7
Immune System Diseases5
Skin Diseases, Eczematous5
Skin Diseases, Genetic4
Genetic Diseases, Inborn3
Hypersensitivity3

Trials

Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.